ARCT · Arcturus Therapeutics Holdings Inc.
Market Cap
$449.65M
Shares
28.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-25 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-07-02 | 2026-06-26 | |
| 8-K | 2026-06-05 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | 2026-05-01 | |
| DEF 14A | 2026-04-24 | 2026-06-05 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2025-12-15 | 2025-12-11 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-09-26 | — | |
| 8-K | 2025-08-29 | — | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-06 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-25 | 2025-06-06 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-06-24 | 2024-06-19 | |
| 8-K | 2024-06-14 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-14 | |
| 8-K | 2024-04-05 | — | |
| 8-K | 2024-03-19 | — | |
| 8-K/A | 2024-03-14 | 2024-03-07 | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-02-23 | 2024-02-20 | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-11-14 | — | |
| 8-K | 2023-09-26 | 2023-09-25 | |
| 8-K | 2023-08-14 | 2023-08-10 | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-07-14 | 2023-07-13 | |
| 8-K | 2023-06-30 | — | |
| 8-K | 2023-06-16 | 2023-06-14 |
Showing 1–50 of 124 filings
Key facts
CIK
1768224
CUSIP
03969T109
13F (30d)
89 filings
89 filers
Visit website
Investor relations